256 related articles for article (PubMed ID: 2757659)
1. Metabolism and excretion of 14C-tiropramide after single intravenous or peroral administration to the rat.
Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
Arzneimittelforschung; 1989 Mar; 39(3):328-34. PubMed ID: 2757659
[TBL] [Abstract][Full Text] [Related]
2. Tiropramide and metabolites in blood and plasma after intravenous or peroral administration of 14C-tiropramide to the rat.
Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
Arzneimittelforschung; 1988 Dec; 38(12):1815-9. PubMed ID: 3245854
[TBL] [Abstract][Full Text] [Related]
3. Distribution of tiropramide and metabolites after single intravenous or peroral administration of 14C-tiropramide to the rat.
Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
Arzneimittelforschung; 1989 May; 39(5):579-86. PubMed ID: 2757674
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of tiropramide after single doses in man.
Arigoni R; Chisté R; Drovanti A; Makovec F; Senin P; Setnikar I
Arzneimittelforschung; 1986 Apr; 36(4):738-44. PubMed ID: 3718598
[TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
8. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
Timchalk C; Smith FA; Bartels MJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical studies with oxitropium bromide. 1. Pharmacokinetics and metabolism in the rat and dog].
Wahl D; Förster HJ; Pook KH; Richter I
Arzneimittelforschung; 1985; 35(1A):255-65. PubMed ID: 4039166
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution and excretion of DL-gamma-amino-beta-hydroxybutyric acid-1-14C (GABOB-1-14C) in the rat.
Bonardi G; Mondino A; Silvestri S; Zanolo G
Arzneimittelforschung; 1981; 31(11):1910-3. PubMed ID: 7198473
[TBL] [Abstract][Full Text] [Related]
12. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
18. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.
Hackett AM; Griffiths LA
Drug Metab Dispos; 1981; 9(1):54-9. PubMed ID: 6111433
[TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism and excretion of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-difluoromethoxyphenyl)- 1,4-dihydropyridine (PP-1466) in rats.
Inoue Y; Nakayama K; Wachi M; Kumakura K; Matsumoto T; Iwamoto M; Motoyoshi Y; Aikawa K
Arzneimittelforschung; 1985; 35(5):813-8. PubMed ID: 4026905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
